CVDACTION: Innovation to transform the prevention of cardiovascular disease

Thousands of avoidable heart attacks and strokes would be prevented every year if more patients with high risk conditions like blood pressure, cholesterol, diabetes and chronic kidney disease received NICE recommended treatments.

CVDACTION makes it much easier for clinicians in primary care to spot patients who are high risk and undertreated, so that their care can be rapidly optimised.

CVDACTION has been successfully trialled in 10 demonstrator sites in London covering a population of 500,000 people. Read the CVDACTION evaluation report on what we learnt from the implementation at these demonstrator sites.

Dr Matt Kearney is leading further development of CVDACTION. Across London and UCLPartners’ geography, Matt will provide this leadership through his role as Senior Advisor at UCLPartners. To scale CVDACTION beyond this area, Matt has established at spin-out company called Into-Action.Health

Implementing CVDACTION

The CVDACTION Implementation Playbook provides a step-by-step guide to using the CVDACTION dashboard and implementing the wider CVDACTION framework.

As part of the Playbook you can find out more about how demonstrator sites implemented CVDACTION.

For more information

Please visit and contact Into-Action.Health.